CervoMed
CRVO • NASDAQ
CervoMed is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John J. Alam, with a market cap of $34.4M.
Market Cap$34.4M
Employees8.0
CEOJohn J. Alam
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
CervoMed FAQ
Common questions about CervoMed
CervoMed is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $117.5K.
CervoMed has approximately 8 employees.